A Study to Evaluate the Glucagon and Incretin Responses and Identify the Role of Extrapancreatic Glucagon in Patients with Fibrocalcific Pancreatic Diabetes

被引:0
|
作者
Shankar, Anand
机构
关键词
D O I
10.2337/db21-224-LB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
224-LB
引用
收藏
页数:3
相关论文
共 50 条
  • [41] PANCREATIC BETA-CELL FUNCTION IN CIRRHOTIC-PATIENTS WITH AND WITHOUT OVERT DIABETES - C-PEPTIDE RESPONSE TO GLUCAGON AND TO MEAL
    MARCHESINI, G
    MELLI, A
    CHECCHIA, GA
    MATTIOLI, L
    CAPELLI, M
    CASSARANI, S
    ZOLI, M
    PISI, E
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (08): : 695 - 701
  • [42] Glucagon Responses to Increasing Oral Loads of Glucose and Corresponding Isoglycemic Intravenous Glucose Infusions in Patients with Type 2 Diabetes and Healthy Subjects
    Knop, Filip K.
    Bagger, Jonatan O.
    Lund, Asger
    Vestergaard, Henrik
    Holst, Jens J.
    Vilsboll, Tina
    DIABETES, 2009, 58 : A368 - A368
  • [43] Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals
    Bagger, Jonatan I.
    Knop, Filip K.
    Lund, Asger
    Holst, Jens J.
    Vilsboll, Tina
    DIABETOLOGIA, 2014, 57 (08) : 1720 - 1725
  • [44] Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals
    Jonatan I. Bagger
    Filip K. Knop
    Asger Lund
    Jens J. Holst
    Tina Vilsbøll
    Diabetologia, 2014, 57 : 1720 - 1725
  • [45] Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes
    Thomsen, C
    Storm, H
    Holst, JJ
    Hermansen, K
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (03): : 605 - 611
  • [46] Incretin-based pharmacotherapy and risk of adverse pancreatic events in patients with diabetes mellitus: A population-based study
    Tseng, Chao-Ming
    Hsu, Yao-Chun
    Chang, Chi-Yang
    Lin, Jaw-Town
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 10 - 10
  • [47] IMPAIRED GLUCAGON-RESPONSES TO INSULIN-INDUCED HYPOGLYCEMIA (IIH) ARE ASSOCIATED WITH IMPAIRED ACTIVATION OF PANCREATIC PARASYMPATHETIC NERVES IN DOGS WITH SPONTANEOUS DIABETES-MELLITUS
    HAVEL, PJ
    DUESBERG, C
    ELLIOTT, D
    GINGERICH, RL
    FELDMAN, EC
    NELSON, RW
    DIABETES, 1995, 44 : A216 - A216
  • [48] Glucagon-Like Peptide-1 Receptor Agonists and Capsule Endoscopy in Patients With Diabetes: A Matched Cohort Study
    Odah, Tarek
    Vattikonda, Asrita
    Stark, Mark
    Brahmbhatt, Bhaumik
    Lukens, Frank J.
    Badurdeen, Dilhana S.
    Hashash, Jana G.
    Farraye, Francis A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S579 - S579
  • [49] Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study
    Odah, Tarek
    Vattikonda, Asrita
    Stark, Mark
    Brahmbhatt, Bhaumik
    Lukens, Frank J.
    Badurdeen, Dilhana
    Hashash, Jana G.
    Farraye, Francis A.
    GASTROINTESTINAL ENDOSCOPY, 2025, 101 (02) : 393 - 401
  • [50] Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
    Parker, Victoria E. R.
    Hoang, Thuong
    Schlichthaar, Heike
    Gibb, Fraser W.
    Wenzel, Barbara
    Posch, Maximillian G.
    Rose, Ludger
    Chang, Yi-Ting
    Petrone, Marcella
    Hansen, Lars
    Ambery, Philip
    Jermutus, Lutz
    Heerspink, Hiddo J. L.
    McCrimmon, Rory J.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1360 - 1369